<code id='C3C5F8021A'></code><style id='C3C5F8021A'></style>
    • <acronym id='C3C5F8021A'></acronym>
      <center id='C3C5F8021A'><center id='C3C5F8021A'><tfoot id='C3C5F8021A'></tfoot></center><abbr id='C3C5F8021A'><dir id='C3C5F8021A'><tfoot id='C3C5F8021A'></tfoot><noframes id='C3C5F8021A'>

    • <optgroup id='C3C5F8021A'><strike id='C3C5F8021A'><sup id='C3C5F8021A'></sup></strike><code id='C3C5F8021A'></code></optgroup>
        1. <b id='C3C5F8021A'><label id='C3C5F8021A'><select id='C3C5F8021A'><dt id='C3C5F8021A'><span id='C3C5F8021A'></span></dt></select></label></b><u id='C3C5F8021A'></u>
          <i id='C3C5F8021A'><strike id='C3C5F8021A'><tt id='C3C5F8021A'><pre id='C3C5F8021A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:214
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Readout Newsletter: XBI biotech index, Akero Therapeutics
          Readout Newsletter: XBI biotech index, Akero Therapeutics

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Readout Newsletter: What happened with Sarepta's Duchenne data

          AndrewHarnik/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnews